University Medical Devices (UMD) today announced the closure of its first round of seed funding. UMD – which brings to market cutting-edge healthcare technology from the University of Nebraska Medical Center and its commercialization wings UNeMed/UNeTech – raised $1.6 million…
Virginia-based company Journey Health & Lifestyle Brands (Journey) has named Adam Karp as its new Chief Executive Officer and a member of the Board of Directors. Adam previously co-founded and led Lively Hearing, Inc. (Lively), a direct-to-consumer hearing aid company,…
The third Physician Sentiment Survey (PSS) by athenahealth, conducted by The Harris Poll, indicates significant challenges facing America’s healthcare industry. Excessive administrative tasks, staffing shortages, financial concerns, and heightened patient expectations for communication are among the key contributors. The survey,…
Carestream Health is set to exhibit its expanding array of cutting-edge medical imaging solutions at the European Congress of Radiology (ECR), held from February 28 to March 3 at the Vienna Building. Leveraging its extensive expertise in imaging research spanning…
Biote Corp. (NASDAQ: BTMD), a leader in personalized hormone optimization and therapeutic wellness, has announced a binding term sheet with Dr. Gary S. Donovitz, Biote’s founder and stockholder, to settle ongoing litigation. As part of the agreement, Biote will repurchase…
United Therapeutics Corporation (Nasdaq: UTHR) has initiated legal action against the United States Food and Drug Administration (FDA), as announced today. The litigation centers on United Therapeutics’ claim that the FDA erroneously allowed Liquidia Corporation (Liquidia) to circumvent established FDA…
AskBio Initiates Phase II Gene Therapy Trial for Heart Failure Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a subsidiary of Bayer AG, have announced the randomization of the first patient in GenePHIT (Gene PHosphatase Inhibition Therapy), a Phase II trial…
Bio-Rad’s 2023 Financial Results Announced Today, Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a prominent figure in life science research and clinical diagnostics, unveiled its financial results for the fourth quarter and full year ending December 31, 2023. In the…
Forecast for Global Retinal Surgery Device Markets (2022-2030) – Company Profiles, Major Deals, Strategies, and Recent Developments The report on the Global Retinal Surgery Devices Market, including Device Segments, Applications, Regional Analysis, Company Profiles, Major Deals, Strategies, and Recent Developments,…
GE HealthCare Tech Inc. Prices 13M Share Secondary Offering GE HealthCare Technologies Inc. (Nasdaq: GEHC) announced the pricing of its previously announced secondary underwritten public offering (the “Offering”) of 13,000,000 shares of its common stock (the “GEHC Shares”) at a…
Healthcare Data Interoperability: Opportunities & Forecast to 2028 – Moving Towards Semantic Interoperability – ResearchAndMarkets.com The “Global Healthcare Data Interoperability Forecast to 2028” report is now available on ResearchAndMarkets.com. Interoperability in Healthcare: Trends, Challenges, and Opportunities Interoperability in healthcare refers…
FDA Clears Xolair as Sole Treatment for Food Allergies in Children and Adults Genentech, a member of the Roche Group, disclosed today that the U.S. Food and Drug Administration (FDA) has granted approval for Xolair® (omalizumab) to mitigate allergic reactions,…